Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Zonal Business Manager Delhi (Office) India International Innovative Medicines Sales Oct 01, 2024
Zonal Business Manager Mumbai (Head Office) India International Innovative Medicines Sales Oct 01, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
TERRITORY BUSINESS EXECUTIVE-1 Rajasthan India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Apr 16, 2024
Territory Business Executive Assam India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Orissa India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Gujarat India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Telangana India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Madhya Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Madhya Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Chattisgarh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Kerala India International Innovative Medicines Sales Oct 01, 2024
TERRITORY BUSINESS EXECUTIVE Delhi Territory India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Jammu & Kashmir India International Innovative Medicines Sales Oct 01, 2024
TERRITORY BUSINESS EXECUTIVE Rajasthan India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Telangana India International Innovative Medicines Sales Oct 14, 2024
Territory Business Executive Chandigarh (Territory) India International Innovative Medicines Sales Oct 14, 2024
Technology Product Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 11, 2024
Team Leader Hyderabad (Office) India Operations CTS Marketing Sep 03, 2024
Team Lead, Data Services Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Oct 23, 2024
Tax Specialist Mumbai (Head Office) India Finance Corporate Audit & Finance Oct 20, 2024
Tactical Planner Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 23, 2024
T&L Operational Expert Hyderabad (Office) India Operations Innovative Medicines Human Resources Oct 04, 2024
Sr.Territory Business Executive Madhya Pradesh India International Innovative Medicines Sales Oct 03, 2024
Sr.Spec.DDIT ISC Gov Indep.Control Asses Hyderabad (Office) India Operations CTS Technology Transformation Sep 18, 2024
Sr. Specialist Quality Management Hyderabad (Office) India Operations CTS Technology Transformation Oct 21, 2024
Sr. Specialist DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Oct 17, 2024
Sr. Specialist DDIT ISC CSOC Engineering Hyderabad (Office) India Operations CTS Technology Transformation Oct 07, 2024
Sr. Specialist DDIT APD ERP PlatformTech Hyderabad (Office) India Operations CTS Technology Transformation Apr 23, 2024
Sr. Specialist (SAP Business Process Automation) Hyderabad (Office) India Operations CTS Technology Transformation Oct 23, 2024
Sr. Special. DDIT IES O365 eDLS Ops Hyderabad (Office) India Operations CTS Technology Transformation May 29, 2024
Sr. Spec. DDIT ISC SecOps IAM Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Sr. Spec. DDIT ISC SecOps Cyber Tools Hyderabad (Office) India Operations CTS Technology Transformation May 07, 2024
Sr. Spec. DDIT ISC QNova Hyderabad (Office) India Operations CTS Technology Transformation Sep 24, 2024

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia